UBS Group’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-149,612
| Closed | -$13.5K | – | 9224 |
|
|
2023
Q3 | $13.5K | Buy |
149,612
+149,362
| +59,745% | +$13.4K | ﹤0.01% | 5849 |
|
|
2023
Q2 | $23 | Buy |
250
+150
| +150% | +$14 | ﹤0.01% | 7597 |
|
|
2023
Q1 | $26 | Hold |
100
| – | – | ﹤0.01% | 8299 |
|
|
2022
Q4 | $21 | Sell |
100
-5
| -5% | -$1 | ﹤0.01% | 9347 |
|
|
2022
Q3 | $0 | Hold |
105
| – | – | ﹤0.01% | 10562 |
|
|
2022
Q2 | $0 | Hold |
105
| – | – | ﹤0.01% | 10513 |
|
|
2022
Q1 | $0 | Sell |
105
-9,266
| -99% | – | ﹤0.01% | 10273 |
|
|
2021
Q4 | $9K | Buy |
9,371
+4,073
| +77% | +$3.91K | ﹤0.01% | 7874 |
|
|
2021
Q3 | $9K | Sell |
5,298
-1,512
| -22% | -$2.57K | ﹤0.01% | 7023 |
|
|
2021
Q2 | $12K | Buy |
6,810
+4,124
| +154% | +$7.27K | ﹤0.01% | 6846 |
|
|
2021
Q1 | $5K | Buy |
2,686
+1,870
| +229% | +$3.48K | ﹤0.01% | 7354 |
|
|
2020
Q4 | $2K | Sell |
816
-969
| -54% | -$2.38K | ﹤0.01% | 7149 |
|
|
2020
Q3 | $5K | Buy |
1,785
+1,680
| +1,600% | +$4.71K | ﹤0.01% | 6487 |
|
|
2020
Q2 | $0 | Hold |
105
| – | – | ﹤0.01% | 7661 |
|
|
2020
Q1 | $0 | Buy |
105
+100
| +2,000% | – | ﹤0.01% | 7600 |
|
|
2019
Q4 | $0 | Sell |
5
-4,676
| -100% | – | ﹤0.01% | 7524 |
|
|
2019
Q3 | $3K | Buy |
4,681
+4,576
| +4,358% | +$2.93K | ﹤0.01% | 6734 |
|
|
2019
Q2 | $0 | Sell |
105
-6,169
| -98% | – | ﹤0.01% | 7398 |
|
|
2019
Q1 | $17K | Buy |
6,274
+2,136
| +52% | +$5.79K | ﹤0.01% | 5629 |
|
|
2018
Q4 | $9K | Buy |
4,138
+214
| +5% | +$465 | ﹤0.01% | 6393 |
|
|
2018
Q3 | $18K | Buy |
3,924
+1,062
| +37% | +$4.87K | ﹤0.01% | 5961 |
|
|
2018
Q2 | $13K | Buy |
2,862
+501
| +21% | +$2.28K | ﹤0.01% | 6093 |
|
|
2018
Q1 | $17K | Sell |
2,361
-4,427
| -65% | -$31.9K | ﹤0.01% | 5659 |
|
|
2017
Q4 | $48K | Sell |
6,788
-5,434
| -44% | -$38.4K | ﹤0.01% | 4929 |
|
|
2017
Q3 | $102K | Buy |
12,222
+11,021
| +918% | +$92K | ﹤0.01% | 4438 |
|
|
2017
Q2 | $13K | Buy |
1,201
+651
| +118% | +$7.05K | ﹤0.01% | 5676 |
|
|
2017
Q1 | $6K | Sell |
550
-5,311
| -91% | -$57.9K | ﹤0.01% | 6016 |
|
|
2016
Q4 | $75K | Buy |
5,861
+4,088
| +231% | +$52.3K | ﹤0.01% | 4612 |
|
|
2016
Q3 | $32K | Sell |
1,773
-4,694
| -73% | -$84.7K | ﹤0.01% | 5001 |
|
|
2016
Q2 | $69K | Sell |
6,467
-103,485
| -94% | -$1.1M | ﹤0.01% | 4443 |
|
|
2016
Q1 | $2.08M | Sell |
109,952
-8,294
| -7% | -$157K | ﹤0.01% | 2117 |
|
|
2015
Q4 | $3.15M | Sell |
118,246
-738
| -0.6% | -$19.6K | ﹤0.01% | 1853 |
|
|
2015
Q3 | $5.43M | Buy |
118,984
+23,133
| +24% | +$1.05M | ﹤0.01% | 1429 |
|
|
2015
Q2 | $3.09M | Buy |
95,851
+16,882
| +21% | +$544K | ﹤0.01% | 1982 |
|
|
2015
Q1 | $2.51M | Buy |
78,969
+49,718
| +170% | +$1.58M | ﹤0.01% | 2125 |
|
|
2014
Q4 | $1.11M | Buy |
+29,251
| New | +$1.11M | ﹤0.01% | 2672 |
|